PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Early delivery and prolonged treatment with nimodipine prevents the development of spasticity after spinal cord injury in mice.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32295897 ↗2020Reported benefit

Early delivery and prolonged treatment with nimodipine prevents the development of spasticity after spinal cord injury in mice.

MouseSpinal cord injuryUnspecifiedStarted in the acute phase after spinal cord injury

Model: Chronic spinal cord injury model in mice

Nimodipine started in the acute phase completely prevented development of spasticity, measured as increased muscle tone and spontaneous spasms. The inhibition of aberrant muscle activity persisted after treatment ended, and Cav1.3 was shown to mediate the effect.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.